Associate Director, US​/Global Forecasting - Hampton, NJ

Overview

Celldex is pioneering new horizons in immunology to deliver life-changing therapies. We are relentless in our pursuit of novel antibody-based treatments that engage the human immune system and directly affect critical pathways to improve the lives of patients with allergic, inflammatory and autoimmune disorders. We have built a culture where innovative and talented people thrive—focusing a significant effort on attracting and retaining passionate and motivated employees who want to play a role in helping people with serious health conditions and who see this effort as personally rewarding.

In our highly entrepreneurial environment, employees are empowered and the opportunity for professional development occurs every day.

Celldex is now entering an exciting new chapter – building a commercial teamto launch barzolvolimab - the most advanced anti-KIT therapy in pivotal development that has the potential to redefine treatment for multiple allergy and dermatological diseases with Phase 3 studies in CSU, ColdU, SD and phase 2 studies in AD and PN. We’re looking for curious, driven builders who can connect their day-to-day work to enterprise-level impact, endlessly prioritize what matters most, and deliver on their commitments with urgency and ownership.

If you’re energized by building something meaningful, excited to grow personally and professionally, and motivated to create lasting impact in a fast-moving, entrepreneurial environment, we’d love to meet you.

Ready to make an impact? Learn more about joining the Celldex Team today!

Reporting to the Senior Director of Commercial Insights and Analytics, the Associate Director of US/Global Forecasting will serve as the point person in the Insights & Analytics unit for barzolvolimab revenue forecasting in the US and for regions outside of the US. As Celldex works toward barzolvolimab's first launch in CSU, this person will be critical in integrating inputs from Insights, Marketing, Commercial Operations, Sales, Global Value & Access, Manufacturing Operations & Supply, and other Celldex functions.

• Build, update, and maintain the operational forecasting models for barzolvolimab including scenario planning, sensitivity analysis, and risk assessments in the US and outside of the US across disclosed and undisclosed indications
• Collaborate cross-functionally with market research to build demand-based forecasts
• Further development and ensure assumption alignment across functions (including Insights, Market Access, Marketing, Sales, Supply Chain, etc.)
• Present forecasting assumptions, logic, and outputs to senior leadership and the executive team, where appropriate
• Guide the design of primary market research studies to validate or create forecast assumptions
• Conduct epidemiological and claims-based studies to determine the size of market opportunities
• Support other financial analysis efforts

• Bachelor's degree in a relevant field or equivalent in experience (e.g., Finance, Economics, Engineering, Statistics, Pharmacy, or Life Sciences)
• Advanced degree strongly preferred (MBA, MD, PharmD, PhD, or Masters in Biostatistics/Quantitative discipline)
• A minimum of 6 years of relevant experience in forecasting, market research, strategic planning, and/or management consulting; previous biotech industry experience is preferred
• Minimum of 3 years’ experience serving as the single source of truth for commercial revenue expectations in a forecasting role for the US and outside of US markets, including responsibility for an operational forecast
• Expert-level Excel modeling (both short-range and long-range forecasting, sensitivity analysis, scenario tools, operational forecasting)
• Firm understanding of forecasting methodologies in pharma/biotech: prevalence-based, incidence-based, TRx-based, patient flow, analog-based, etc.
• Ability to deliver these responsibilities in a highly dynamic market environment, including effectively generating forecasting/modeling scenarios through periods of disruption and discontinuity, including new market approvals and biosimilar entrants
• Ability to understand and translate market insights, qualitative research, access…